Dr Michael Kolodziej Discusses the Role of Commercial Payers in Value-Based Care
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.
Transcript
Are commercial payers beginning to have a bigger presence in value-based care?
The issue with commercial payers is that they’re very interesting in doing things that are easy for them administratively. I don’t think they’re going to embrace [Oncology Care Model]. It’s just too complicated. It’s just too much work. I believe pathways are going to be—and you can certainly define pathways as value-based care. In fact, there is no definition of value-based care. There’s a broad spectrum of what constitutes value-based care, and pathways clearly exists within that spectrum.
I think payers will all adopt some sort of “value-based care program.” It might not be what the folks at OncoCloud consider value-based care, but it is by the strictest sense of the word a model of care.
